CIPO trademark

MIDATECH

RegisteredCIPOWord markClass 1Class 5Class 9Class 10+2

"MIDATECH" is a word mark owned by Midatech Limited, filed at the CIPO on April 2, 2013. It is registered and covers classes 1, 5, 9, 10, 40 and 42.

View Midatech Limited portfolio Get this data via the API

Data current as of April 29, 2026Official CIPO record

MIDATECH

Word mark as filed with the CIPO

Status: Registered; Since June 18, 2019
Filed: April 2, 2013
Registered: June 18, 2019
Expires: June 18, 2029
Application no.: 1620638
Registration no.: TMA1027227
Office: CIPO; Canadian Intellectual Property Office
Mark type: Word mark; 6 classes

Ownership

Who owns MIDATECH

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Midatech Limited

United Kingdom

37 trademarks in the portfolioView company

Representative

Borden Ladner Gervais LLP

Goods and services

What the mark covers

The products and services MIDATECH is filed for, grouped by Nice class.

01Class 1 · Chemicals
Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines; nano-particle ingredients for use in pharmaceuticals, medicines and cosmetics; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, and hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of hormonal diseases and disorders, namely hormone replacement therapy preparations, pancreas hormone preparations, thyroid and para-thyroid hormone preparations, adrenal hormone preparations, and pituitary hormone preparations; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; human vaccines incorporating nano-particles; veterinary vaccines incorporating nano-particles; computer software for the sampling, collection, analysis and testing of nano-particles; computer software for the diagnosis of medical conditions, namely viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, and cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; electronic devices, namely, computers, laboratory analyzers, probes, spectroscopic devices, namely laboratory spectroscopes, microfluidic devices, namely electronic analyzers for the transport and analysis for fluid samples by using microfluidic and nanofluidic channels formed on or in a substrate, digital microfluidic instruments for nucleic acid sample preparation, and digital microfluidic instruments for genomic analysis, microarray devices, namely laboratory microarray instruments for the sampling, collection, analysis and testing of nano-particles, assays, for the sampling, collection, analysis and testing of nano-particles; medical devices, namely, medical diagnostic kits consisting primarily of probes, buffers and reagents for use in nano-particle testing, spectroscopic devices namely microscopes for surgical operations, endoscopic equipment, otoscopes, and medical diagnostic instuments for analysis of body fluids, microarray devices namely, in the nature of microarrays for surgical use, microarrays for medical diagnostic use, and microarrays for the sampling, collection, analysis and testing of nano-particles for medical purposes, assays, for the sampling, collection, analysis and testing of nano-particles.; Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines; nano-particle ingredients for use in pharmaceuticals, medicines and cosmetics; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, and hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of hormonal diseases and disorders, namely hormone replacement therapy preparations, pancreas hormone preparations, thyroid and para-thyroid hormone preparations, adrenal hormone preparations, and pituitary hormone preparations; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; human vaccines incorporating nano-particles; veterinary vaccines incorporating nano-particles.
05Class 5 · Pharmaceuticals
Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines; nano-particle ingredients for use in pharmaceuticals, medicines and cosmetics; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, and hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of hormonal diseases and disorders, namely hormone replacement therapy preparations, pancreas hormone preparations, thyroid and para-thyroid hormone preparations, adrenal hormone preparations, and pituitary hormone preparations; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; human vaccines incorporating nano-particles; veterinary vaccines incorporating nano-particles; computer software for the sampling, collection, analysis and testing of nano-particles; computer software for the diagnosis of medical conditions, namely viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, and cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; electronic devices, namely, computers, laboratory analyzers, probes, spectroscopic devices, namely laboratory spectroscopes, microfluidic devices, namely electronic analyzers for the transport and analysis for fluid samples by using microfluidic and nanofluidic channels formed on or in a substrate, digital microfluidic instruments for nucleic acid sample preparation, and digital microfluidic instruments for genomic analysis, microarray devices, namely laboratory microarray instruments for the sampling, collection, analysis and testing of nano-particles, assays, for the sampling, collection, analysis and testing of nano-particles; medical devices, namely, medical diagnostic kits consisting primarily of probes, buffers and reagents for use in nano-particle testing, spectroscopic devices namely microscopes for surgical operations, endoscopic equipment, otoscopes, and medical diagnostic instuments for analysis of body fluids, microarray devices namely, in the nature of microarrays for surgical use, microarrays for medical diagnostic use, and microarrays for the sampling, collection, analysis and testing of nano-particles for medical purposes, assays, for the sampling, collection, analysis and testing of nano-particles.; Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines; nano-particle ingredients for use in pharmaceuticals, medicines and cosmetics; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, and hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of hormonal diseases and disorders, namely hormone replacement therapy preparations, pancreas hormone preparations, thyroid and para-thyroid hormone preparations, adrenal hormone preparations, and pituitary hormone preparations; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; human vaccines incorporating nano-particles; veterinary vaccines incorporating nano-particles.
09Class 9 · Computers and Scientific Devices
Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines; nano-particle ingredients for use in pharmaceuticals, medicines and cosmetics; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, and hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of hormonal diseases and disorders, namely hormone replacement therapy preparations, pancreas hormone preparations, thyroid and para-thyroid hormone preparations, adrenal hormone preparations, and pituitary hormone preparations; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; human vaccines incorporating nano-particles; veterinary vaccines incorporating nano-particles; computer software for the sampling, collection, analysis and testing of nano-particles; computer software for the diagnosis of medical conditions, namely viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, and cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; electronic devices, namely, computers, laboratory analyzers, probes, spectroscopic devices, namely laboratory spectroscopes, microfluidic devices, namely electronic analyzers for the transport and analysis for fluid samples by using microfluidic and nanofluidic channels formed on or in a substrate, digital microfluidic instruments for nucleic acid sample preparation, and digital microfluidic instruments for genomic analysis, microarray devices, namely laboratory microarray instruments for the sampling, collection, analysis and testing of nano-particles, assays, for the sampling, collection, analysis and testing of nano-particles; medical devices, namely, medical diagnostic kits consisting primarily of probes, buffers and reagents for use in nano-particle testing, spectroscopic devices namely microscopes for surgical operations, endoscopic equipment, otoscopes, and medical diagnostic instuments for analysis of body fluids, microarray devices namely, in the nature of microarrays for surgical use, microarrays for medical diagnostic use, and microarrays for the sampling, collection, analysis and testing of nano-particles for medical purposes, assays, for the sampling, collection, analysis and testing of nano-particles.; Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines; nano-particle ingredients for use in pharmaceuticals, medicines and cosmetics; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, and hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of hormonal diseases and disorders, namely hormone replacement therapy preparations, pancreas hormone preparations, thyroid and para-thyroid hormone preparations, adrenal hormone preparations, and pituitary hormone preparations; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; human vaccines incorporating nano-particles; veterinary vaccines incorporating nano-particles.
10Class 10 · Medical Apparatus
Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines; nano-particle ingredients for use in pharmaceuticals, medicines and cosmetics; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, and hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of hormonal diseases and disorders, namely hormone replacement therapy preparations, pancreas hormone preparations, thyroid and para-thyroid hormone preparations, adrenal hormone preparations, and pituitary hormone preparations; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; human vaccines incorporating nano-particles; veterinary vaccines incorporating nano-particles; computer software for the sampling, collection, analysis and testing of nano-particles; computer software for the diagnosis of medical conditions, namely viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, and cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; electronic devices, namely, computers, laboratory analyzers, probes, spectroscopic devices, namely laboratory spectroscopes, microfluidic devices, namely electronic analyzers for the transport and analysis for fluid samples by using microfluidic and nanofluidic channels formed on or in a substrate, digital microfluidic instruments for nucleic acid sample preparation, and digital microfluidic instruments for genomic analysis, microarray devices, namely laboratory microarray instruments for the sampling, collection, analysis and testing of nano-particles, assays, for the sampling, collection, analysis and testing of nano-particles; medical devices, namely, medical diagnostic kits consisting primarily of probes, buffers and reagents for use in nano-particle testing, spectroscopic devices namely microscopes for surgical operations, endoscopic equipment, otoscopes, and medical diagnostic instuments for analysis of body fluids, microarray devices namely, in the nature of microarrays for surgical use, microarrays for medical diagnostic use, and microarrays for the sampling, collection, analysis and testing of nano-particles for medical purposes, assays, for the sampling, collection, analysis and testing of nano-particles.; Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines; nano-particle ingredients for use in pharmaceuticals, medicines and cosmetics; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, and hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of hormonal diseases and disorders, namely hormone replacement therapy preparations, pancreas hormone preparations, thyroid and para-thyroid hormone preparations, adrenal hormone preparations, and pituitary hormone preparations; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; human vaccines incorporating nano-particles; veterinary vaccines incorporating nano-particles.
40Class 40 · Treatment of Materials
Custom manufacture of nano-particles in the field of nano-particle technology, pharmaceuticals and nano-medicine; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of electronic nano-particle devices, namely computers, laboratory analyzers, probes, spectroscopic devices, microfluidic devices, microarray devices, and assays for the sampling, collection, analysis and testing of nano-particles; custom manufacture of medical nano-particle devices, namely medical diagnostic kits, medical sample preparation devices, spectroscopic devices, microfluidic devices, microarray devices, and assays for the sampling, collection, analysis and testing of nano-particles; scientific research services in the field of nano-particle technology; pharmaceutical and drug development and discovery services; testing, efficiency and advisory services in the field of nano-particles, pharmaceuticals and nano-medicine; nano-particle laboratory services.
42Class 42 · Computer and Scientific Services
Custom manufacture of nano-particles in the field of nano-particle technology, pharmaceuticals and nano-medicine; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of electronic nano-particle devices, namely computers, laboratory analyzers, probes, spectroscopic devices, microfluidic devices, microarray devices, and assays for the sampling, collection, analysis and testing of nano-particles; custom manufacture of medical nano-particle devices, namely medical diagnostic kits, medical sample preparation devices, spectroscopic devices, microfluidic devices, microarray devices, and assays for the sampling, collection, analysis and testing of nano-particles; scientific research services in the field of nano-particle technology; pharmaceutical and drug development and discovery services; testing, efficiency and advisory services in the field of nano-particles, pharmaceuticals and nano-medicine; nano-particle laboratory services.

History

What has happened so far

Steps recorded by the CIPO, newest first.

June 18, 2019Registered
January 25, 2019Extension of Time; Online Request Date: 2019/01/25
July 5, 2018Extension of Time; Online Request Date: 2018/07/05
January 18, 2018Extension of Time; Online Request Date: 2018/01/18
June 27, 2017Extension of Time; Online Request Date: 2017/06/27
February 6, 2017Extension of Time; Online Request Date: 2017/02/06
July 28, 2016Extension of Time; Online Request Date: 2016/07/28
February 12, 2016Allowance Notice Sent
February 12, 2016Allowed
October 28, 2015Advertised; Vol.62 Issue 3183

9 earlier steps on the official record.

FAQ

About MIDATECH

Who owns the trademark "MIDATECH"?

The CIPO trademark "MIDATECH" (application 1620638) is owned by Midatech Limited.

What is the status of "MIDATECH"?

Its status at the CIPO is: registered.

When was "MIDATECH" registered?

It was registered on June 18, 2019 and is due to expire on June 18, 2029.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MIDATECH and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019deb25-db34-7145-957a-8270c06efc3a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019deb25-db34-7145-957a-8270c06efc3a",
  "object": "trademark",
  "mark_text": "MIDATECH",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "1620638",
  "filing_date": "2013-04-02",
  "nice_classes": [
    1,
    5,
    9,
    10,
    40,
    42
  ],
  "owners": [
    {
      "name": "Midatech Limited",
      "entity_id": "ent_019ebaf3-9aef-735b-a6dd-65e4baf52602"
    }
  ]
}